Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study

Kazuo Sugita,Kazuyoshi Kawakami,Takashi Yokokawa,Takahito Sugisaki,Tomomi Takiguchi,Takeshi Aoyama,Kenichi Suzuki,Mitsukuni Suenaga,Kensei Yamaguchi,Ayaka Inoue,Yoshiaki Machida,Toshiharu Yamaguchi,Toshihiro Hama

Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study

2016

Kazuo Sugita
Kazuyoshi Kawakami
Takashi Yokokawa
Takahito Sugisaki
Tomomi Takiguchi
Takeshi Aoyama
Kenichi Suzuki
Mitsukuni Suenaga
Kensei Yamaguchi
Ayaka Inoue
Yoshiaki Machida
Toshiharu Yamaguchi
Toshihiro Hama

Background: A novel oral agent that consists of trifluridine and tipiracil hydrochloride (TFTD) has been established as salvage-line treatment for metastatic colo

Keywords:

Neutropenia
Tipiracil hydrochloride
Trifluridine
Colorectal cancer
Medicine
Oncology
Retrospective cohort study
Nausea
Internal medicine
Vomiting
oral agents

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations